Adductor Canal Block With IPACK Versus Genicular Nerves Block With IPACK for Post-operative Analgesia
IPACK
Comparative Study Between Adductor Canal Block With IPACK (Infiltration Between the Popliteal Artery and Capsule of the Knee) Versus Genicular Nerves Block With IPACK for Post-operative Analgesia in Knee Arthroscopy
1 other identifier
interventional
72
1 country
1
Brief Summary
In our study, we will find out the efficacy of those peripheral nerve blocks on postoperative pain in knee arthroscopy. The aim is to evaluate the efficacy of combined ultrasound-guided IPACK with adductor canal nerve block versus ultrasound-guided IPACK with genicular nerves block on postoperative pain in knee arthroscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
December 2, 2025
October 1, 2025
1 year
November 20, 2025
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
first analgesic request
the first time the patient will ask analgesia postoperative
within 24 hours
Secondary Outcomes (3)
Changes in Visual Analogue Score
To be measured immediately postoperative, 2h later, 4h, 6h, 8h, 12h, 18h, 24h
Total analgesic requirement
within 24 hours
Time Up and Go Test (TUG)
postoperative: 6h, 12h, 18h and 24h.
Study Arms (3)
IA (IPACK with adductor cannal block)
ACTIVE COMPARATORreceive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then another 15 ml of 0.25% plain bupivacaine at the mid-thigh for the ACB.
IG (IPACK with genicular nerves block)
ACTIVE COMPARATORreceive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then at the anterior surface of the knee 16 ml of 0.25% plain bupivacaine divided on the 4 genicular nerves (superior medial, superior lateral, inferior medial and inferior lateral).
C (Spinal block)
ACTIVE COMPARATORwon't receive any nerve block, only spinal anesthesia. \- Then spinal anesthesia will be given to all patients in the three groups, 3 ml (15 mg) 0.5% hyperbaric bupivacaine will be administered intrathecal at level of L3-4 or L4-5 interspace.
Interventions
receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then another 15 ml of 0.25% plain bupivacaine at the mid-thigh for the ACB.
receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then at the anterior surface of the knee 16 ml of 0.25% plain bupivacaine divided on the 4 genicular nerves (superior medial, superior lateral, inferior medial and inferior lateral).
won't receive any nerve block, only spinal anesthesia. \- Then spinal anesthesia will be given to all patients in the three groups, 3 ml (15 mg) 0.5% hyperbaric bupivacaine will be administered intrathecal at level of L3-4 or L4-5 interspace.
Eligibility Criteria
You may qualify if:
- ASA l \& ll
- planned to undergo elective unilateral knee surgeries under spinal anesthesia
- age between 20 to 70 years old
- both sex
You may not qualify if:
- Patient refusal
- Neurological deficiencies prior to surgery
- Severe Cardiovascular, renal and hepatic comorbidities
- Hematological disorders and abnormal coagulation parameters
- Psychiatric illnesses and opioid addiction
- Allergies to any of the medications will be utilized in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minia University Hospital
Minya, Minya Governorate, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gehad Fathy Sadek, MD
Minia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Anesthesiology and ICU
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 2, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
December 2, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share